B. Desqueper

Humanized severe combined immunodeficient mice as a potential model for the study of tolerance to factor VIII.

J. Vermylen, J. Saint-Remy, J. Gilles, 2000, Thrombosis and haemostasis.

A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor.

J. Vermylen, L. Vander Elst, K. Thielemans, 2000, Blood.

Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor.

M F Hoylaerts, J. Vermylen, L. Vander Elst, 1998, Blood.

Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.

J. Vermylen, J. Saint-Remy, H. Lenk, 1996, The Journal of clinical investigation.

Deletion of residue Ala2201 in the Factor VIII C2 domain results in mild haemophilia A and destroys a major antigenic determinant recognized by Factor VIII inhibitor antibodies

B. Stoddard, J. Vermylen, K. Peerlinck, 2001 .